Advertisement
Screener

Apyx Medical Corp (APYX) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

2.8 / 5 stars · 68/120 Roast Me

Apyx Medical Corp Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 165.51K shares.
  • Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 119.08K shares.
  • Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 249.55K shares.
  • Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 25.59K shares.
  • Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 275.14K shares, a 48255.54% increase from fiscal 2024.
  • Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 569.00 shares, a 99.00% decline from fiscal 2023.
  • Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 57.00K shares, a 81.99% decline from fiscal 2022.
  • Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 316.51K shares, a 36.12% increase from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month
2026-06-30165.51K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
559.73K shares
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31119.08K shares
10-Q · filed 2026-05-07
394.22K shares
derived: sum of 4 quarters · filed 2026-05-07
2025-12-31249.55K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10
275.14K shares
10-K · filed 2026-03-10
2025-09-3025.59K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
25.59K shares
derived: sum of 4 quarters · filed 2026-03-10
2025-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
0.00 shares
derived: sum of 4 quarters · filed 2026-03-10
2025-03-310.00 shares
10-Q · filed 2025-05-08
0.00 shares
derived: sum of 4 quarters · filed 2026-03-10
2024-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10
569.00 shares
10-K · filed 2026-03-10
2024-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08
569.00 shares
derived: sum of 4 quarters · filed 2025-03-13
2024-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
22.57K shares
derived: sum of 4 quarters · filed 2025-03-13
2024-03-31569.00 shares
10-Q · filed 2024-05-09
57.57K shares
derived: sum of 4 quarters · filed 2025-03-13
2023-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13
57.00K shares
10-K · filed 2025-03-13
2023-09-3022.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
74.50K shares
derived: sum of 4 quarters · filed 2024-03-21
2023-06-3035.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11
231.67K shares
derived: sum of 4 quarters · filed 2024-03-21
2023-03-310.00 shares
10-Q · filed 2023-05-11
250.67K shares
derived: sum of 4 quarters · filed 2024-03-21
2022-12-3117.50K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21
316.51K shares
10-K · filed 2024-03-21
2022-09-30179.17K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
422.11K shares
derived: sum of 4 quarters · filed 2023-03-16
2022-06-3054.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
296.78K shares
derived: sum of 4 quarters · filed 2023-03-16
2022-03-3165.84K shares
10-Q · filed 2022-05-12
254.28K shares
derived: sum of 4 quarters · filed 2023-03-16
2021-12-31123.11K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
232.52K shares
10-K · filed 2023-03-16
2021-09-3053.83K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
141.25K shares
derived: sum of 4 quarters · filed 2022-03-17
2021-06-3011.50K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
124.17K shares
derived: sum of 4 quarters · filed 2022-03-17
2021-03-3144.08K shares
10-Q · filed 2021-05-12
141.42K shares
derived: sum of 4 quarters · filed 2022-03-17
2020-12-3131.83K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17
112.97K shares
10-K · filed 2022-03-17
2020-09-3036.75K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
100.63K shares
derived: sum of 4 quarters · filed 2021-03-31
2020-06-3028.75K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
146.47K shares
derived: sum of 4 quarters · filed 2021-03-31
2020-03-3115.63K shares
10-Q · filed 2020-05-11
155.72K shares
derived: sum of 4 quarters · filed 2021-03-31
2019-12-3119.50K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31
410.63K shares
10-K · filed 2021-03-31
2019-09-3082.59K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-15
492.13K shares
derived: sum of 4 quarters · filed 2020-05-08
2019-06-3038.00K shares
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2019-08-07
1.65M shares
derived: sum of 4 quarters · filed 2020-05-08
2019-03-31270.55K shares
10-Q/A · filed 2020-05-08
2018-12-31101.00K shares
derived: 10-K 12 month − 10-Q/A 9 month · filed 2020-03-31
1.38M shares
10-K · filed 2020-03-31
2018-09-301.24M shares
derived: 10-Q/A 9 month − 10-Q 6 month · filed 2020-05-08
2017-12-3172.25K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-31
176.75K shares
10-K · filed 2020-03-31
2016-12-3136.28K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14
36.25K shares
10-K · filed 2019-03-14
2015-12-31194.50K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10
97.50K shares
10-K · filed 2017-03-10
2015-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
9.90K shares
derived: sum of 4 quarters · filed 2016-03-18
2015-06-30-97.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07
2015-03-315.00 shares
10-Q · filed 2015-05-08
2014-12-31106.90K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-18
107.00K shares
10-K · filed 2016-03-18
2013-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
51.00K shares
10-K · filed 2015-02-27
2013-09-3050.96K shares
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-14
53.00K shares
derived: sum of 4 quarters · filed 2014-05-08
2013-06-30-29.96K shares
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2013-09-25
8.04K shares
derived: sum of 4 quarters · filed 2014-05-08
2013-03-3130.00K shares
10-Q · filed 2013-05-15
2012-12-312.00K shares
derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-05-08
28.00K shares
10-K/A · filed 2014-05-08
2012-09-306.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14
2011-12-3169.00K shares
10-K · filed 2013-04-01
2010-12-3146.00 shares
10-Q · filed 2011-08-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Microbot Medical Inc. (MBOT)$0.089B-7.97
KORU Medical Systems, Inc. (KRMD)United States$0.151B-106.78
LENSAR, Inc. (LNSR)United States$0.087B2.02
SkinHealth Systems Inc. (SKIN)United States$0.086B-3.17
Pulmonx Corp (LUNG)United States$0.082B-1.16
RenovoRx, Inc. (RNXT)United States$0.076B-3.62
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18
Lucid Diagnostics Inc. (LUCD)United States$0.170B
CVRx, Inc. (CVRX)United States$0.067B-2.62
DarioHealth Corp. (DRIO)$0.066B-1.39